Xumanii (XUII) – Yesterday, after a nail-biting session XUII managed to climb to a new 52-week high, which gave the company a market valuation of $150 million. At the end of the day, XUII had finished 11% higher at $0.44 per share on above average volume of 18.7 million.

The excitement about XUII continues today as the stock opened the session with a gap up at $0.46 per share but after 10:00 the stock fell down below the previous close hitting an intraday low at $0.41 per share.

Currently shares of XUII stock are trading 0.23% lower at $0.439 per share on a below average volume of 7 million. Apparently, buyers and sellers are grappling for the control over XUII today, which promises an emotionally intense trading session that will show whether the stock will manage to finish at new record highs at the end of the day.

Meanwhile no additional press releases have been issued since Wednesday when the company announced it had merged with its wholly owned subsidiary. This, however, hasn’t prevented the stock from claiming once again the number one place among the most actively traded penny stocks on the OTC Market.

Liquidmetal Technologies, Inc. (LQMT) – Today, LQMT is rallying after yesterday’s correction which took the stock down 41% to $0.12 per share on a much higher than average volume of 116 million.

Currently shares of LQMT stock are trading 19% higher at $0.142 per share on a higher than average volume of 23 million. The trading interest towards LQMT keeps rising as new publications about Apple’s new patent appear.

Thus, yesterday LQMT was featured in another publication on Los Angeles Times named “”Apple appears one step closer to rolling out Terminator-like iPhone”. With publications like that keeping the buzz around LQMT it looks like these days the stock will remain in the focus of the OTC Markets.

InVivo Therapeutics Holdings Corp (NVIV) – NVIV is resolutely climbing up today but is presently facing a resistance at $5.45. The stock opened the trading session with a gap up at $5.2 after which it shot up to a new 52-week high at $5.44.

Currently shares of NVIV stock are trading 5% higher at $5.4 per share on a below average volume of 244 thousand. Today, NVIV may show if the strong bullish impulse which has charged the stock in the last couple of months will be enough for the stock to push above the resistance at $5.45.

NVIV keeps going up without any new press releases issued by the company, while its CEO keeps profiting from the stock’s momentum by selling chunks of his position in NVIV every week.

Cellceutix Corp. (CTIX) – Today shares of CTIX stock are trading 6% higher at $2.04 per share on a higher than average volume of 585 thousand. SO far CTIX has generated a trade value of 1.2 million which has put the stock in the OTC Markets list of most actively traded stocks.

The intensive trading which CTIX is facing today is not produced by any press releases or stock promotions. The last news update from the company was issued on June 26 when CTX announced that it had signed a material transfer agreement with the University of Texas M. D. Anderson Cancer Center.